InvestorsHub Logo
Followers 3
Posts 313
Boards Moderated 0
Alias Born 06/18/2013

Re: None

Wednesday, 05/01/2019 2:25:56 PM

Wednesday, May 01, 2019 2:25:56 PM

Post# of 83028
Joe Dowling, CEO of CV Sciences, Inc., was featured on TDAmeritrade discussing the company’s expansion into the Food, Drug & Mass Channel & the current research that is being conducted on #hemp CBD.

Dowling discussed the recent positive research on PTSD. "I think the results were very promising" Dowling said. "Again this is just the beginning of the research."

Dowling went on to stress that PTSD is very hard to treat and that opioids are currently the front-line treatment. "If there is alternative to that, and we certainly think CBD can be an alternative, that will be very positive."

Dowling also discussed the addition of CVS as a major distributor who he now considers a partner. He explained the large retailers are starting with topical, but ingestible products are soon.

Click the link below to watch the full interview. #CVSI http://bit.ly/2Vb8D0f